HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Viral respiratory infection — Clinical Guidelines

Overview

Viral respiratory infections encompass a wide range of illnesses caused by viruses such as influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, affecting the respiratory tract and potentially leading to severe complications including multi-organ failure 10.

Diagnosis

Clinical symptoms include fever, cough, sore throat, and respiratory distress.

Diagnostic tests: RT-PCR for viral RNA detection, antigen detection tests, and serological assays 11.

Imaging: Chest X-rays or CT scans may be used to assess severity and complications 10.

Management

Supportive Care: Oxygen therapy, hydration, and rest 5.

Antiviral Therapy: Oseltamivir or zanamivir for influenza; remdesivir or monoclonal antibodies for severe COVID-19 cases (specific dosing not detailed in abstracts) 5.

Immunomodulatory: Vitamin D supplementation may help regulate immune response and reduce inflammation 5.

Infection Control: Aggressive infection control measures, including hand hygiene, isolation, and vaccination of healthcare personnel 15.

Special Populations

Pediatrics: Long-term consequences of pediatric viral infections warrant close monitoring and follow-up 6.

Elderly: Higher risk of severe complications and multi-organ failure; require vigilant supportive care 10.

Comorbidities: Patients with underlying conditions like cardiovascular disease may experience more severe outcomes, including multisystem organ failure 14.

Key Recommendations

Implement aggressive infection control measures in healthcare settings to reduce nosocomial transmission of viral respiratory infections (Evidence: Strong 15).

Consider vitamin D supplementation to modulate immune response in patients with respiratory viral infections (Evidence: Moderate 5).

Prioritize vaccination of healthcare personnel against influenza to decrease transmission rates (Evidence: Moderate 15).

Monitor pediatric patients closely for long-term sequelae following viral respiratory infections (Evidence: Expert opinion 6).

Tailor supportive care based on severity, including oxygen therapy and intensive monitoring in elderly and comorbid patients (Evidence: Moderate 10 14).

References

1 Saif LJ. A Passion for Small Things and Staying Primed: My Career in Virology and Immunology. Annual review of animal biosciences 2025. link 2 Akbar R, Fatima S, Rahman SU, Malik A, Akhtar S, Siddiqi NJ et al.. Immunoinformatics-Driven Design of a Multi-Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention. Reviews in medical virology 2025. link 3 Ratnasiri K, Zheng H, Toh J, Yao Z, Duran V, Donato M et al.. Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans. Cell reports 2024. link 4 Beltrán JF, Belén LH, Yáñez AJ, Jimenez L. Predicting viral proteins that evade the innate immune system: a machine learning-based immunoinformatics tool. BMC bioinformatics 2024. link 5 Vaghari-Tabari M, Mohammadzadeh I, Qujeq D, Majidinia M, Alemi F, Younesi S et al.. Vitamin D in respiratory viral infections: a key immune modulator?. Critical reviews in food science and nutrition 2023. link 6 Rowe RK, Mohr EL. Special Issue "Pediatric Viral Infection Long-Term Consequences". Viruses 2022. link 7 Morgado-Palacin L. Bo Zhong: Captive by the viral immune escape. The Journal of cell biology 2022. link 8 Hirschfeld AS. Autoimmune mediated hyperkinetic movement disorders in SARS-CoV-2 infection - a systematic review. Neurologia i neurochirurgia polska 2021. link 9 Susi P. Special Issue: Virus Receptors and Viral Tropism. Viruses 2021. link 10 Lombardi AF, Afsahi AM, Gupta A, Gholamrezanezhad A. Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), influenza, and COVID-19, beyond the lungs: a review article. La Radiologia medica 2021. link 11 Li Y, He XZ, Li MH, Li B, Yang MJ, Xie Y et al.. Comparison of third-generation sequencing approaches to identify viral pathogens under public health emergency conditions. Virus genes 2020. link 12 Martínez-Lázaro C, Taneco-Hernández MA, Reyes-Carreto R, Vargas-De-León C. Existence of a Conserved Quantity and Stability of . Computational and mathematical methods in medicine 2019. link 13 Murray JM, Ribeiro RM. Special Issue "Mathematical Modeling of Viral Infections". Viruses 2018. link 14 Fill MA, Compton ML, McDonald EC, Moncayo AC, Dunn JR, Schaffner W et al.. Novel Clinical and Pathologic Findings in a Heartland Virus-Associated Death. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017. link 15 Dare RK, Talbot TR. Health Care-Acquired Viral Respiratory Diseases. Infectious disease clinics of North America 2016. link 16 Schneider DS. What Can Vampires Teach Us about Immunology?. Trends in immunology 2016. link 17 Jung YJ, Kim JH, Park YJ, Kahng J, Lee H, Lee KY et al.. Evaluation of cell population data on the UniCel DxH 800 Coulter Cellular Analysis system as a screening for viral infection in children. International journal of laboratory hematology 2012. link 18 Bocharov G, Züst R, Cervantes-Barragan L, Luzyanina T, Chiglintsev E, Chereshnev VA et al.. A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections. PLoS pathogens 2010. link 19 Zinkernagel RM. On 'reactivity' versus 'tolerance'. Immunology and cell biology 2004. link 20 Doherty PC. The pas de deux of viruses and CD8 T cells. Immunological reviews 2002. link 21 Zheng WF, Cui Z, Zhu Q. Cytotoxicity and antiviral activity of the compounds from Euphorbia kansui. Planta medica 1998. link 22 Marx G, Mou X, Freed R, Ben-Hur E, Yang C, Horowitz B. Protecting fibrinogen with rutin during UVC irradiation for viral inactivation. Photochemistry and photobiology 1996. link 23 Edelman JM, Chan BM, Uniyal S, Onodera H, Wang DZ, St John NF et al.. The mouse VLA-2 homologue supports collagen and laminin adhesion but not virus binding. Cell adhesion and communication 1994. link 24 Kauffmann S, Legrand M, Fritig B. Isolation and characterization of six pathogenesis-related (PR) proteins of Samsun NN tobacco. Plant molecular biology 1990. link 25 Johnston MI, Hearl WG, White JC, Imai J, Torrence PF, Williams RW. Immunochemistry, physical chemistry and biology of 2',5'-oligoadenylates. Progress in clinical and biological research 1985. link 26 van der Groen G, Pattyn SR. Delayed multiplication of Semliki forest virus in organ cultures of muscle from vaccinated mice. Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 1976. link 27 Schmidt NJ, Lennette EH. Comparison of various methods for preparation of viral serological antigens from infected cell cultures. Applied microbiology 1971. link 28 Wagner RR, Heine JW, Goldstein G, Schnaitman CA. Use of antiviral-antiferritin hybrid antibody for localization of viral antigen in plasma membrane. Journal of virology 1971. link 29 Rosenstein RW, Nisonoff A, Uhr JW. Significance of bivalence of antibody in viral neutralization. The Journal of experimental medicine 1971. link

Viral respiratory infection